KIP Medical’s Post

The future of medicine lies at the intersection of nature and science. At KIP Medical, we're pioneering this approach with our work on Spilanthes acmella. By combining traditional uses with modern research, we're developing innovative solutions for those who are in need. Read about the future of natural product drug discovery: https://lnkd.in/dRvz-Pkt #NatureAndScienceMedicine #PioneeringNaturalMedicine #TraditionalWisdomModernSolutions #SpilanthesAcmellaInnovation #NextGenNaturalProducts #BridgingTheGapInHealthcare #FutureOfNaturalMedicine #BotanicalDrugDiscovery #PlantBasedDrugDevelopment #NaturalProductRevolution #HarnessingNatureForHealth #SustainableMedicineSolutions #MedicalInnovationForPatients #DevelopingSolutionsForNeeds #NaturalHealingForAll #ImprovingLivesThroughScience #HealthcareEquity #PatientCareFocus #HealthInnovation #AlternativeMedicine #ComplementaryMedicine #NaturalHealing #FutureOfMedicine #ReadMore #JoinTheMovement #NaturalMedicineAdvocate

Nice article on PGX. Especially important is the MD/PharmD collaboration mentioned. At Tsela Labs, We believe this collaborative effort is the key to a successful and compliant Personalized Medicine program. https://lnkd.in/eRQn4bCb

“When a specialized field of medicine has long been quiet, a buzz of breakthrough can seem like a sudden development. The reality is more nuanced,” writes Jula Inrig, M.D., chief medical officer at Travere. Check out her recent article about #RareKidneyDisease and #IgAnephropathy in Fierce Biotech. #InRareForLife https://bit.ly/3BGDsA3

1️⃣ Boston Scientific’s cardiac rhythm system hits pivotal trial goals. Boston Scientific, which presented the results at the Heart Rhythm Society meeting, expects to receive FDA approval for the system in 2025. 2️⃣ KT has introduced two new patches for diabetes care, featuring Pro Extreme adhesive to prevent CGM device detachment. 3️⃣ Click Therapeutics, Inc. has acquired assets from Better Therapeutics, potentially enhancing its portfolio in obesity, diabetes, and cardiometabolic diseases. 4️⃣ Indica Labs received FDA 510(k) clearance for its HALO AP Dx platform, which diagnoses surgical pathology slides. 5️⃣ Irmed’s PressureSafe device has shown to reduce pressure injury incidence by half in early detections. 6️⃣ Invizius completed a Phase I trial of its dialysis priming product, H-Guard, confirming its safety and efficacy. 7️⃣ Allez Health raised $60m led by Osang Healthcare to enhance its diabetes sensor technology. 8️⃣ MEDLINE INDUSTRIES LIMITED, LP introduced the TurboMist small-volume nebuliser, delivering medication more efficiently than standard nebulisers. #InsightswithSmarteeva #Medtech #complaintmanagement #Pharma #Smarteeva #biotech #medtechtrends #medtechindustry #medicaltechnology #technology #health #medicaldevicediagnostics #ai #mdr #recalls #complaints #mir #fda #cvr

Better understand AD treatment effectiveness as Raj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, review clinical data on tapinarof cream, 1%, in treating #AtopicDermatitis. Watch here: https://ow.ly/oPE950R8IFk

Delighted to present our first review on microneedles. https://lnkd.in/dKSA25Sr. We discussed the current trends observed in the microneedle landscape, with particular emphasis on contemporary clinical trials and commercial successes. Additionally, we examined the barriers impeding microneedle development and commercialization. #Microneedles #ClinicalTrials #HealthcareInnovation #Research #MedicalTechnology

Four Keys To Advancing Antisense Oligonucleotides For Personalized Medicine. #LifeSciences #RangLifeciences #RangTechnologies #RangHealthcare #RangCares #IMatterAlly https://lnkd.in/dr5prQAc

Prof. Fredric O. Finkelstein, M.D., is joining Byonyks as a scientific advisor. Before joining the company, he wrote the following article. I'm excited to share that it validates the important work we are doing at Byonyks to revolutionize peritoneal dialysis (PD). The article published in Kidney International Reports highlights the critical need for innovations in PD to reduce inflammation, preserve the peritoneal membrane, and improve patient comfort and outcomes. As the article states, "Innovations in PD are needed to improve patient outcomes and quality of life." This is precisely the mission we are pursuing at Byonyks - to develop next-generation PD devices that are biocompatible, toxin-free, and help preserve peritoneal membrane integrity. Our solutions aim to deliver higher-quality treatments more efficiently, allowing patients to maintain an active lifestyle. We are excited to bring real innovation to the PD space and partner with the nephrology community to elevate patient care. Stay tuned for more updates as we work to commercialize our solutions in the US market. Link: https://lnkd.in/gWSAbUj8

🩺 I'm excited to share a recent review published in Cardiorenal Medicine, "Unlocking the Potential of VExUS in Assessing Venous Congestion: The Art of Doing It Right" by Koratala et al. This article highlights how the Venous Excess Ultrasound (VExUS) score can better quantify venous congestion, improving management of heart failure and critical illnesses. The review emphasizes the advantages of multi-organ Point-of-Care Ultrasound (POCUS) over traditional methods, showcasing its real-time accuracy in assessing fluid overload. It also discusses the importance of understanding technical nuances to avoid clinical errors. This innovative approach promises to enhance patient care, reduce hospital readmissions, and improve outcomes in managing heart failure and critical conditions. #CardioNephrology #VenousCongestion #POCUS #HeartFailure #NephrologyResearch Gregorio Aramid Romero González https://lnkd.in/dsAQV7_n

Don't miss this insightful webinar where you can learn how improvements of the workflow could allow you to accelerate the time to results for the Analysis of FT4 and FT3 as well as the Analysis of Free Testosterone by UPLC™-MS/MS for Clinical Research. #ClinicalResearch #Endocrinology https://lnkd.in/gtCWZGNH